Treace Medical Concepts, Inc. (TMCI)

Treace Medical Concepts Stock Forecast

Stock Price Forecast

The 6 analysts that cover Treace Medical Concepts stock have a consensus rating of "Hold" and an average price target of $9.18, which forecasts a 48.54% increase in the stock price over the next year. The lowest target is $8 and the highest is $14.5.

Price Target: $9.18 (+48.54%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$8.00	$9.18	$8.00	$14.5
Change	+29.45%	+48.54%	+29.45%	+134.63%

* Price targets were last updated on May 9, 2025.

Analyst Ratings

The average analyst rating for Treace Medical Concepts stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	7	7	7	5	5	5
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Danielle Antalffy UBS	UBS	Hold Maintains $10 → $8.6	Hold	Maintains	$10 → $8.6	+39.16%	May 9, 2025
Richard Newitter Truist Securities	Truist Securities	Hold Maintains $9.5 → $8	Hold	Maintains	$9.5 → $8	+29.45%	Apr 11, 2025
Richard Newitter Truist Securities	Truist Securities	Hold Maintains $10 → $9.5	Hold	Maintains	$10 → $9.5	+53.72%	Mar 13, 2025
Richard Newitter Truist Securities	Truist Securities	Hold Maintains $8.4 → $10	Hold	Maintains	$8.4 → $10	+61.81%	Mar 3, 2025
Ben Haynor Lake Street	Lake Street	Strong Buy Initiates $15	Strong Buy	Initiates	$15	+134.63%	Dec 31, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

231.56M

Increased by 10.61%

from 209.36M

Revenue Next Year

255.54M

Increased by 10.36%

from 231.56M

EPS This Year

-0.80

from -0.90

EPS Next Year

-0.67

from -0.80

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	57.37M	94.42M	141.84M	187.12M	209.36M	231.56M	255.54M	275.18M
Revenue Growth	45.54%	64.59%	50.22%	31.92%	11.89%	10.61%	10.36%	7.69%
EPS	-0.12	-0.43	-0.77	-0.81	-0.90	-0.80	-0.67	-0.59
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	9	9	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	238.7M	269.9M	294.4M
Avg	231.6M	255.5M	275.2M
Low	222.2M	241.1M	259.7M

Revenue Growth

Revenue Growth	2025	2026	2027
High	14.0%	16.5%	15.2%
Avg	10.6%	10.4%	7.7%
Low	6.1%	4.1%	1.6%

EPS Forecast

EPS	2025	2026	2027
High	-0.76	-0.46	-0.20
Avg	-0.80	-0.67	-0.59
Low	-0.81	-0.78	-0.78

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.